CD274 and neoplasm: In vivo experiments conducted on B6 mice demonstrated a potent tumor inhibitory effect when combining 5-aminolevulinic acid with anti-PD-L1 mAb, yielding similar results in B16BL6 and C26 models alongside an increase in the T cell population [249].